Literature DB >> 25632141

The role of telomerase protein TERT in Alzheimer's disease and in tau-related pathology in vitro.

Alison Spilsbury1, Satomi Miwa1, Johannes Attems2, Gabriele Saretzki3.   

Abstract

The telomerase reverse transcriptase protein TERT has recently been demonstrated to have a variety of functions both in vitro and in vivo, which are distinct from its canonical role in telomere extension. In different cellular systems, TERT protein has been shown to be protective through its interaction with mitochondria. TERT has previously been found in rodent neurons, and we hypothesize that it might have a protective function in adult human brain. Here, we investigated the expression of TERT at different stages of Alzheimer's disease pathology (Braak Stages I-VI) in situ and the ability of TERT to protect against oxidative damage in an in vitro model of tau pathology. Our data reveal that TERT is expressed in vitro in mouse neurons and microglia, and in vivo in the cytoplasm of mature human hippocampal neurons and activated microglia, but is absent from astrocytes. Intriguingly, hippocampal neurons expressing TERT did not contain hyperphosphorylated tau. Vice versa, neurons that expressed high levels of pathological tau did not appear to express TERT protein. TERT protein colocalized with mitochondria in the hippocampus of Alzheimer's disease brains (Braak Stage VI), as well as in cultured neurons under conditions of oxidative stress. Our in vitro data suggest that the absence of TERT increases ROS generation and oxidative damage in neurons induced by pathological tau. Together, our findings suggest that TERT protein persists in neurons of the adult human brain, where it may have a protective role against tau pathology.
Copyright © 2015 Spilsbury et al.

Entities:  

Keywords:  Alzheimer's disease; mitochondria; neuroprotection; oxidative stress; tau; telomerase

Mesh:

Substances:

Year:  2015        PMID: 25632141      PMCID: PMC4308607          DOI: 10.1523/JNEUROSCI.2925-14.2015

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  88 in total

1.  4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease.

Authors:  L M Sayre; D A Zelasko; P L Harris; G Perry; R G Salomon; M A Smith
Journal:  J Neurochem       Date:  1997-05       Impact factor: 5.372

Review 2.  Telomerase in brain tumors.

Authors:  M L Falchetti; L M Larocca; R Pallini
Journal:  Childs Nerv Syst       Date:  2002-02-23       Impact factor: 1.475

3.  Regulation of NF-κB activity in astrocytes: effects of flavonoids at dietary-relevant concentrations.

Authors:  Alison Spilsbury; David Vauzour; Jeremy P E Spencer; Marcus Rattray
Journal:  Biochem Biophys Res Commun       Date:  2012-01-24       Impact factor: 3.575

4.  Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease.

Authors:  Thomas Fath; Jochen Eidenmüller; Roland Brandt
Journal:  J Neurosci       Date:  2002-11-15       Impact factor: 6.167

5.  Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study.

Authors:  G Lace; G M Savva; G Forster; R de Silva; C Brayne; F E Matthews; J J Barclay; L Dakin; P G Ince; S B Wharton
Journal:  Brain       Date:  2009-03-24       Impact factor: 13.501

6.  Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice.

Authors:  Virginie Rhein; Xiaomin Song; Andreas Wiesner; Lars M Ittner; Ginette Baysang; Fides Meier; Laurence Ozmen; Horst Bluethmann; Stefan Dröse; Ulrich Brandt; Egemen Savaskan; Christian Czech; Jürgen Götz; Anne Eckert
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-06       Impact factor: 11.205

Review 7.  Neurodegenerative diseases and oxidative stress.

Authors:  Kevin J Barnham; Colin L Masters; Ashley I Bush
Journal:  Nat Rev Drug Discov       Date:  2004-03       Impact factor: 84.694

8.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

Authors:  Heiko Braak; Irina Alafuzoff; Thomas Arzberger; Hans Kretzschmar; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2006-08-12       Impact factor: 17.088

9.  Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies.

Authors:  Simon Dujardin; Katia Lécolle; Raphaëlle Caillierez; Séverine Bégard; Nadège Zommer; Cédrick Lachaud; Sébastien Carrier; Noëlle Dufour; Gwennaëlle Aurégan; Joris Winderickx; Philippe Hantraye; Nicole Déglon; Morvane Colin; Luc Buée
Journal:  Acta Neuropathol Commun       Date:  2014-01-30       Impact factor: 7.801

10.  Low abundance of the matrix arm of complex I in mitochondria predicts longevity in mice.

Authors:  Satomi Miwa; Howsun Jow; Karen Baty; Amy Johnson; Rafal Czapiewski; Gabriele Saretzki; Achim Treumann; Thomas von Zglinicki
Journal:  Nat Commun       Date:  2014-05-12       Impact factor: 14.919

View more
  43 in total

1.  Excitotoxic and Radiation Stress Increase TERT Levels in the Mitochondria and Cytosol of Cerebellar Purkinje Neurons.

Authors:  Erez Eitan; Carmel Braverman; Ailone Tichon; Daniel Gitler; Emmette R Hutchison; Mark P Mattson; Esther Priel
Journal:  Cerebellum       Date:  2016-08       Impact factor: 3.847

Review 2.  The non-canonical functions of telomerase: to turn off or not to turn off.

Authors:  Aleksandra Romaniuk; Anna Paszel-Jaworska; Ewa Totoń; Natalia Lisiak; Hanna Hołysz; Anna Królak; Sylwia Grodecka-Gazdecka; Błażej Rubiś
Journal:  Mol Biol Rep       Date:  2018-11-17       Impact factor: 2.316

3.  Telomerase Reverse Transcriptase and p53 Regulate Mammalian Peripheral Nervous System and CNS Axon Regeneration Downstream of c-Myc.

Authors:  Jin-Jin Ma; Xin Ju; Ren-Jie Xu; Wei-Hua Wang; Zong-Ping Luo; Chang-Mei Liu; Lei Yang; Bin Li; Jian-Quan Chen; Bin Meng; Hui-Lin Yang; Feng-Quan Zhou
Journal:  J Neurosci       Date:  2019-10-09       Impact factor: 6.167

Review 4.  Characterizing the "POAGome": A bioinformatics-driven approach to primary open-angle glaucoma.

Authors:  Ian D Danford; Lana D Verkuil; Daniel J Choi; David W Collins; Harini V Gudiseva; Katherine E Uyhazi; Marisa K Lau; Levi N Kanu; Gregory R Grant; Venkata R M Chavali; Joan M O'Brien
Journal:  Prog Retin Eye Res       Date:  2017-02-20       Impact factor: 21.198

Review 5.  Telomerase and neurons: an unusual relationship.

Authors:  Gabriele Saretzki
Journal:  Neural Regen Res       Date:  2022-11       Impact factor: 6.058

Review 6.  Telomere dysfunction in ageing and age-related diseases.

Authors:  Francesca Rossiello; Diana Jurk; João F Passos; Fabrizio d'Adda di Fagagna
Journal:  Nat Cell Biol       Date:  2022-02-14       Impact factor: 28.213

7.  Meta-analysis of Telomere Length in Alzheimer's Disease.

Authors:  Diego A Forero; Yeimy González-Giraldo; Catalina López-Quintero; Luis J Castro-Vega; George E Barreto; George Perry
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-04-18       Impact factor: 6.053

Review 8.  Telomerase in Brain: The New Kid on the Block and Its Role in Neurodegenerative Diseases.

Authors:  Gabriele Saretzki; Tengfei Wan
Journal:  Biomedicines       Date:  2021-04-29

Review 9.  The Power of Stress: The Telo-Hormesis Hypothesis.

Authors:  Maria Sol Jacome Burbano; Eric Gilson
Journal:  Cells       Date:  2021-05-11       Impact factor: 6.600

Review 10.  Potential of Naturally Derived Compounds in Telomerase and Telomere Modulation in Skin Senescence and Aging.

Authors:  Barbara Jacczak; Błażej Rubiś; Ewa Totoń
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.